SBME SYMPOSIUM 2024

Our keynote speaker this year is Dr. George Church, geneticist and founder of Synthetic Biology at Wyss Institute, Harvard University.

AI, data analytics, and automation are set to transform the diagnostics lab of the future

Abstract: Some of the critical challenges in healthcare and diagnostics that affect the quality, efficiency, and access to care include accuracy and early detection of diseases, availability and affordability of healthcare services, labor shortages of qualified professionals, and data overload and paralysis. These challenges require innovative solutions that can improve the outcomes and costs of treatment, as well as the delivery and safety of care. AI-powered diagnostics can improve accuracy and identify diseases earlier by analyzing vast datasets. Personalized medicine can be achieved by analyzing a patient’s unique medical history and genetic data. Automated lab processes and AI-assisted analysis can significantly reduce turnaround times for diagnostic tests. Robotic lab automation can improve efficiency and reduce the risk of human error. Intelligent robots can make decisions based on information they see, increasing efficiency and providing real-time results. Such systems can predict disease outbreaks, identify high-risk populations, and contribute to epidemiological research. AI-powered lab systems in combination with telemedicine could expand access to advanced diagnostics in underserved areas.

Bio: Dr. Rangarajan Sampath, a seasoned professional with over three decades of experience, is celebrated for his visionary leadership in medical technologies, diagnostics, and digital health. Currently serving as the Senior Vice President at Siemens Healthineers, he drives innovation in oncology, neurology, and infectious diseases. Previously, as the Chief Scientific Officer at the Foundation for Innovative New Diagnostics (FIND), he led research and development efforts to bring advanced diagnostics to low- and middle-income countries. Prior to that, during his tenure at Abbott’s Ibis Division, he played a pivotal role in advancing infectious disease diagnostics, co-founding Ibis Biosciences and contributing to the invention of the IRIDICA platform. Dr. Sampath’s contributions extend beyond industry, with over 100 publications and more than 40 issued patents in infectious disease diagnostics. He is actively involved in initiatives such as the Sepsis Alliance, serving on its board, and frequently contributes his expertise to public forums on infectious diseases and healthcare. His research interests encompass a wide range of areas including sepsis, antimicrobial resistance, pathogen discovery, and biothreat detection.

Bio: Dr. Mehmet Kurt is the director of Kurtlab and an Assistant Professor at the University of Washington Department of Mechanical Engineering. Mehmet received his undergraduate degree in Mechanical Engineering from Bogazici University (Istanbul, Turkey) and his Ph.D. in Mechanical Science and Engineering from the University of Illinois at Urbana-Champaign. He was a postdoctoral scholar in the Department of Bioengineering at Stanford University from 2014 to 2016. Prior to joining UW in 2022, he was an Assistant Professor of Mechanical Engineering at Stevens Institute of Technology.

Mehmet’s research is focused on biological and biomedical challenges, particularly in the areas of brain biomechanics, neuromechanics imaging, nonlinear systems, and smart biomedical devices. Some examples of his research projects include investigating the nonlinear dynamics of the human brain during head impacts, studying aneurysm stability through aneurysm wall motion imaging, and measuring brain tissue stiffness in vivo through ultra-high resolution MR Elastography in Alzheimer’s Disease.

His awards include the Lucile Packard Children Hospital Postdoctoral Fellowship, Thrasher Research Foundation Early Career Award, Provost’s Early Career Award for Research Excellence and the Thomas Bernard Hall Prize. His research and neuroimaging work has been recognized with prizes and coverage in the popular media, including an NSF Best Scientific Visualization (Vizzie) Award, being named in the 40 under 40 list in Turkey by Fortune Magazine, and an Annals of Biomedical Engineering Editor’s Choice Award. His research group is currently sponsored by multiple grants from NSF, NIH and DoD. Mehmet is active in a variety of initiatives to increase the participation and visibility of LGBTQ+ students in STEM, including through mentorship programs and outreach events.

Modeling Cancer for Target and Drug Discovery

Abstract: Drug discovery in cancer typically involves screening cells grown on 2-dimensional, hard plastic dishes; however, since human tissue is neither 2D nor plastic, this environment does not sufficiently emulate human disease. To overcome this limitation, we designed hydrogels for 3-dimensional cell culture with the goal of screening cells in an environment that mimics that of native tissue.  With 3D cell culture, we gain an understanding of both cell invasion and cell viability, thereby providing insights that are inherently limited with traditional 2D cell culture.  To achieve a suitable environment, we synthesized hyaluronan-based hydrogels because hyaluronan is often over-expressed in invasive tumours including those in the breast, brain and lung.

To facilitate cell invasion and remodelling of the matrix, the hydrogels are crosslinked with peptides that can be degraded by matrix metalloproteinases (MMPs) secreted by the cells.  We use either Diels-Alder or oxime click chemistry to crosslink our hydrogels while also including polymers that provide viscoelasticity, thereby enabling cells to remodel the 3D hydrogel environment. Thus, cells can invade into the hydrogel by either actively degrading it enzymatically or through ameboid movement. To enhance cell adhesion, the hydrogels are modified with proteins and/or peptides; to facilitate cell invasion, the hydrogels are modified with growth factor concentration gradients.  Importantly, only diseased, and not healthy, cells migrate into the hydrogels.

Using well-defined hyaluronan-based hydrogels, we investigate invasion in the context of breast cancer, brain cancer, lung cancer cell and their response to different therapeutic treatments. In the context of Hodgkin’s lymphoma, we investigate macrophage invasion and whether drug treatments can change polarization and invasion. Ultimately, our goal is to identify new drugs for the treatment of cancer.

Acknowledgments: We are grateful to NSERC, CIHR and Laugh out LAM Foundation for funding. We thank our collaborators, Dr. William Stanford (OHRI), Dr. Peter Dirks (HSC), Dr. Dave Cescon (PMH), Dr. Stephen Juvet (UHN), Dr. Rob Laister (PMH), Dr. John Kuruvilla (PMH), and Dr. Stephane Angers (UofT).

Bio: Molly S. Shoichet is University Professor and Michael E Charles Professor in Chemical Engineering at the University of Toronto. She served as Ontario’s first Chief Scientist and has been awarded numerous honours including Fellow, Royal Society (UK), Fellow, National Academy of Engineering (USA), and NSERC Herzberg Gold Medal – Canada’s highest award for science/engineering, among many others. Dr. Shoichet’s research focuses on innovative 3D cell culture models for drug discovery, and drug and cell delivery strategies to overcome central nervous system-related pathologies. She is a prolific entrepreneur, co-founding multiple spin-off companies, and a passionate advocate for translational research and science communication.

Anna Blakney (She/Her), is an Assistant Professor in the Michael Smith Laboratories and School of Biomedical Engineering at UBC. She received her Bachelor of Science in Chemical & Biological Engineering from the University of Colorado at Boulder, and her PhD in Bioengineering from the University of Washington. She completed a postdoctoral fellowship at Imperial College London on the development of molecular and biomaterial engineering strategies for delivery of self-amplifying RNA. Her lab uses bioengineering, molecular biology and immunology approaches to develop the next generation of RNA vaccines and therapies. She is also a passionate science communicator and runs a TikTok channel dedicated to educating the public about RNA biotechnology, which now has 250,000 followers and 18M views.

Ninan Abraham (He/His), is a Professor in the UBC Department of Microbiology and Immunology and the Department of Zoology and the former Associate Dean, Equity, Diversity and Inclusion at the UBC Faculty of Science. His research focused on the regulatory points in immune cell control in airway immunity to pathogens and lung cancer. While serving as Associate Dean, he had responsibility for equity, diversity and inclusion initiatives and elevated use of disaggregated demographics to unveil differential barriers for racialized minorities in faculty hiring. He has advised CIHR, NSERC and NRC policymakers on best practices. His interests now include health equity for community benefit and Science and Technology Studies. He served on the UBC President’s Anti-Racism and Inclusive Excellence Task Force and is the current Director of EDI&I for CoVaRR-Net, a national network of COVID researchers. 

Madjid Mohseni (He/His), a Professor in the Department of Chemical and Biological Engineering at UBC, is an expert in drinking water quality and treatment. His research involves laboratory scale development and investigation, as well as field evaluation of the technologies under real operating conditions at partner community sites in rural and Indigenous communities.

Madjid is the Scientific Director of “Community Circle on Scaling Business Innovation for Humanity”, a non-profit organization funded by Innovation, Science and Economic Development Canada (ISED), and partners from industry, communities, government and NGOs, focusing on achieving socioeconomically and technologically sustainable outcomes in water health and well-being for Indigenous and rural communities.

Enzo Giacopino (He/His) is a 2nd year PhD student (Shakiba lab) working on human pluripotent stem cells dynamics in organoid differenciation; but also a profound interest on the climate crisis and its relations to science.